Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taro Murai

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Radiation Oncology (London, England)|September 13, 2017
Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second studyAkifumi Miyakawa, Yuta Shibamoto, Fumiya Baba, et al.
Journal of Radiation Research|April 24, 2013
Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experienceKengo Ohta, Masashi Shimohira, Hiromitsu Iwata, et al.
Radiation Oncology (London, England)|March 23, 2013
Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical modeTaro Murai, Yuta Shibamoto, Yoshihiko Manabe, et al.
Journal of Radiation Research|December 20, 2018
Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancerShinya Takemoto, Yuta Shibamoto, Chikao Sugie, et al.
Journal of Radiation Research|January 31, 2016
Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experienceKengo Ohta, Masashi Shimohira, Taro Murai, et al.
Practical Radiation Oncology|November 20, 2014
Intensity modulated stereotactic body radiation therapy for single or multiple vertebral metastases with spinal cord compressionTaro Murai, Rumi Murata, Yoshihiko Manabe, et al.
In Vivo (Athens, Greece)|October 31, 2023
A Unique Adverse Event of Radiotherapy in a Patient With IgG4-related Disease: A Case ReportHisao Aimi, Taro Murai, Kazuki Takino, et al.
Japanese Journal of Radiology|February 8, 2016
Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experienceYukiko Hattori, Taro Murai, Hiromitsu Iwata, et al.
Journal of Radiation Research|April 7, 2020
Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable diseaseSatoshi Ishikura, Takuhito Kondo, Taro Murai, et al.
The Kurume Medical Journal|November 15, 2019
Clinical Evaluation of Onrad, A New Low-cost Version of TomoTherapy that Uses Only Static BeamsTaro Murai, Takeshi Tamura, Tadashi Nakabayashi, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Radiation Oncology (London, England)|September 13, 2017
Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second studyAkifumi Miyakawa, Yuta Shibamoto, Fumiya Baba, et al.
Journal of Radiation Research|April 24, 2013
Percutaneous fiducial marker placement under CT fluoroscopic guidance for stereotactic body radiotherapy of the lung: an initial experienceKengo Ohta, Masashi Shimohira, Hiromitsu Iwata, et al.
Radiation Oncology (London, England)|March 23, 2013
Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical modeTaro Murai, Yuta Shibamoto, Yoshihiko Manabe, et al.
Journal of Radiation Research|December 20, 2018
Long-term results of intensity-modulated radiotherapy with three dose-fractionation regimens for localized prostate cancerShinya Takemoto, Yuta Shibamoto, Chikao Sugie, et al.
Journal of Radiation Research|January 31, 2016
Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experienceKengo Ohta, Masashi Shimohira, Taro Murai, et al.
Practical Radiation Oncology|November 20, 2014
Intensity modulated stereotactic body radiation therapy for single or multiple vertebral metastases with spinal cord compressionTaro Murai, Rumi Murata, Yoshihiko Manabe, et al.
In Vivo (Athens, Greece)|October 31, 2023
A Unique Adverse Event of Radiotherapy in a Patient With IgG4-related Disease: A Case ReportHisao Aimi, Taro Murai, Kazuki Takino, et al.
Japanese Journal of Radiology|February 8, 2016
Chemoradiotherapy for localized extranodal natural killer/T-cell lymphoma, nasal type, using a shrinking-field radiation strategy: multi-institutional experienceYukiko Hattori, Taro Murai, Hiromitsu Iwata, et al.
Journal of Radiation Research|April 7, 2020
Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable diseaseSatoshi Ishikura, Takuhito Kondo, Taro Murai, et al.
The Kurume Medical Journal|November 15, 2019
Clinical Evaluation of Onrad, A New Low-cost Version of TomoTherapy that Uses Only Static BeamsTaro Murai, Takeshi Tamura, Tadashi Nakabayashi, et al.
Pageof 6